Biocryst
Develops medicines for hereditary angioedema and other rare diseases for patients with unmet treatment needs
Highlights
- New on EvolcAdded 2026-11-13
About Biocryst
BioCryst is a commercial-stage biotechnology company that discovers, develops and commercializes oral small-molecule and injectable protein therapeutics, focusing on hereditary angioedema and other rare diseases.
Its medicines are developed for patients with rare diseases, and the company also commercializes treatments. BioCryst was founded in 1986 and is headquartered in Durham, North Carolina, with a regional office in Boston, Massachusetts.
Product: Oral small-molecule and injectable protein therapeutics for hereditary angioedema and other rare diseases.
Jobs at Biocryst
More biotech & pharma companies
Biocytogen
Drug discovery platforms, animal models and preclinical research services for pharmaceutical and biotechnology companiesNew on EvolcBluerocktx
Develops cell therapies for patients with degenerative diseases, including neurology and ophthalmology conditionsNew on EvolcBraeburn
Pharmaceutical company marketing BRIXADI, a prescription product for opioid use disorder treatmentNew on EvolcBridgeBio Pharma
Develops drugs for rare genetic conditions, including ATTR amyloidosis, achondroplasia and muscular dystrophyGrowingRemote-friendlyBristolmyerssquibb
Discovers, develops and supplies medicines for patients with serious diseases worldwidecAMPfield Therapeutics
Clinical-stage biopharma developing prifemilast, an oral PDE4B inhibitor, for ulcerative colitis and Crohn's diseaseYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Forms
- Gravity FormsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Privacy & consent
- CookiebotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.